Quinazoline derivatives as Src tyrosine kinase inhibitors

Details Quinazoline derivatives as Src tyrosine kinase inhibitors Quinazoline derivatives as Src tyrosine kinase inhibitors

2003-10-29

2008-12-09

Wilson, James O. (Department: 1624)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C544S284000

Reexamination Certificate

active

07462623

ABSTRACT:
The invention concerns quinazoline derivatives of Formula (I): (A chemical formula should be inserted here—please see paper copy enclosed herewith) wherein Z is an O, S, SO, SO2, N(R2) or C(R2)2group wherein each R2group is hydrogen or (1-8C) alkyl, m is 0, 1, 2 or 3, each R1group is selected from halogeno, (1-8C) alkyl, (1-6C) alkoxy and any of the other meanings defined in the description, n is 0, 1, 2 or 3, and each R3group is selected from halogeno, (1-8C) alkyl, (1-6C) alkoxy and any of the other meanings defined in the description, or pharmaceutically-acceptable salts thereof, processes for their preparation, pharmaceutical compositions containing them and their use in the manufacture of a medicament for use as an anti-invasive agent in the containment and/or treatment of solid tumor disease.

REFERENCES:
patent: 5576322 (1996-11-01), Takase et al.
patent: 5580870 (1996-12-01), Barker et al.
patent: 5693652 (1997-12-01), Takase et al.
patent: 5801180 (1998-09-01), Takase et al.
patent: 5866572 (1999-02-01), Barker et al.
patent: 5962458 (1999-10-01), Lohmann et al.
patent: 6046206 (2000-04-01), Pamukcu et al.
patent: 6071921 (2000-06-01), Lohmann et al.
patent: 6184225 (2001-02-01), Thomas et al.
patent: 6258951 (2001-07-01), Lohmann et al.
patent: 6265411 (2001-07-01), Thomas et al.
patent: 6291455 (2001-09-01), Thomas et al.
patent: 6294532 (2001-09-01), Thomas et al.
patent: 6362336 (2002-03-01), Lohmann et al.
patent: 6399602 (2002-06-01), Barker et al.
patent: 6414148 (2002-07-01), Thomas et al.
patent: 6514971 (2003-02-01), Thomas et al.
patent: 6673803 (2004-01-01), Thomas et al.
patent: 6809097 (2004-10-01), Thomas et al.
patent: 6849625 (2005-02-01), Lambert et al.
patent: 6887874 (2005-05-01), Hennequin
patent: 6897210 (2005-05-01), Thomas et al.
patent: 6897214 (2005-05-01), Barker et al.
patent: 6939866 (2005-09-01), Lambert et al.
patent: 7049438 (2006-05-01), Hennequin et al.
patent: 7074800 (2006-07-01), Hennequin et al.
patent: 7087602 (2006-08-01), Thomas et al.
patent: 7115615 (2006-10-01), Hennequin et al.
patent: 7141577 (2006-11-01), Ple
patent: 7160889 (2007-01-01), Hennequin et al.
patent: 7173038 (2007-02-01), Thomas et al.
patent: 7262201 (2007-08-01), Hennequin et al.
patent: 7268230 (2007-09-01), Hennequin
patent: 2006/0142297 (2006-06-01), Barge
patent: 2006/0223815 (2006-10-01), Curwen et al.
patent: 0607439 (2002-01-01), None
patent: 0602851 (2002-10-01), None
patent: WO 92/20642 (1992-11-01), None
patent: 95/15758 (1995-06-01), None
patent: WO 95/15758 (1995-06-01), None
patent: WO 96/09294 (1996-03-01), None
patent: WO 96/39145 (1996-12-01), None
patent: 97/03069 (1997-01-01), None
patent: WO 97/03069 (1997-01-01), None
patent: WO 97/30035 (1997-08-01), None
patent: WO 97/32856 (1997-09-01), None
patent: WO 97/34876 (1997-09-01), None
patent: WO 97/42187 (1997-11-01), None
patent: WO 98/02434 (1998-01-01), None
patent: WO 98/13350 (1998-04-01), None
patent: WO 98/13354 (1998-04-01), None
patent: WO 99/10349 (1999-03-01), None
patent: WO 00/18761 (2000-04-01), None
patent: WO 00/21955 (2000-04-01), None
patent: WO 00/47212 (2000-08-01), None
patent: WO 01/21594 (2001-03-01), None
patent: WO 01/21597 (2001-03-01), None
patent: WO 01/32651 (2001-05-01), None
patent: WO 01/66099 (2001-09-01), None
patent: WO 01/74360 (2001-10-01), None
patent: WO 01/77085 (2001-10-01), None
patent: WO 01/94341 (2001-12-01), None
patent: 02/16352 (2002-02-01), None
patent: WO 02/12226 (2002-02-01), None
patent: WO 02/12227 (2002-02-01), None
patent: WO 02/12228 (2002-02-01), None
patent: WO 02/16352 (2002-02-01), None
patent: WO 02/30924 (2002-04-01), None
patent: WO 02/30926 (2002-04-01), None
patent: WO 92/34744 (2002-05-01), None
patent: WO 02/085895 (2002-10-01), None
patent: WO 02/092577 (2002-11-01), None
patent: WO 02/092578 (2002-11-01), None
patent: WO 02/092579 (2002-11-01), None
patent: WO 03/008409 (2003-01-01), None
patent: WO 03/039551 (2003-05-01), None
patent: WO 03/047582 (2003-06-01), None
patent: WO 03/064413 (2003-08-01), None
patent: WO 2004/004732 (2004-01-01), None
patent: WO 2004/005284 (2004-01-01), None
patent: WO 2004/014383 (2004-02-01), None
patent: WO 2004/014426 (2004-02-01), None
patent: WO 2004/032937 (2004-04-01), None
patent: WO 2004/043472 (2004-05-01), None
patent: WO 2004/071397 (2004-08-01), None

Affiliated with

Also associated with

Rating

Quinazoline derivatives as Src tyrosine kinase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Quinazoline derivatives as Src tyrosine kinase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Quinazoline derivatives as Src tyrosine kinase inhibitors will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4028575